TO STUDY THE CLINICAL SPECTRUM OF ALCOHOL LIVER DISEASE IN TERTIARY CARE CENTER

Main Article Content

Dr. Sagar Malviya
Dr. Dolly Joseph

Keywords

Jaundice, ascitis, decompensated cirrhosis, chronic Alcoholic consumption,

Abstract

Background: Alcoholic liver disease (ALD) is a major contributor to global morbidity and mortality, encompassing a spectrum of conditions from steatosis to cirrhosis.  


AIM: To evaluate the demographic profile, alcohol intake patterns, and clinical spectrum of ALD in patients at a tertiary care hospital in India.


Material and Methods: A single-center, hospital-based cross-sectional study was conducted over 18 months, including 100 adult patients with confirmed ALD. Data on demographics, alcohol consumption patterns, and clinical features were collected through structured interviews and clinical assessments. Laboratory parameters and ultrasound findings were also analyzed.


Results:  Participants were predominantly male (92%), with a mean age of 48 years. The prevalence of alcoholic cirrhosis was 70% (including 28 patients with decompensated cirrhosis) and 30% had hepatic steatosis (fatty liver) and alcoholic hepatitis. Heavy alcohol consumption (≥720 units/month) was strongly associated with advanced ALD, including cirrhosis (86%) and decompensated cirrhosis (38%) (p < 0.001). Chronic alcohol consumption (>20 years) correlated with higher prevalence of cirrhosis (89%). Common clinical manifestations included jaundice (55%), ascites (35%), and hepatic encephalopathy (15%). Laboratory findings revealed elevated SGOT/SGPT ratios (>2), hypoalbuminemia, and anemia. Ultrasound abnormalities such as coarse liver echotexture were prevalent in 70%.


Conclusion: This study highlights the role of heavy and prolonged alcohol consumption in disease progression. The findings underscore the need for targeted interventions to reduce alcohol-related liver damage and improve clinical outcomes.

Abstract 27 | pdf Downloads 7

References

1. NIH. Alcohol’s Effects on the Body | National Institute on Alcohol Abuse and Alcoholism (NIAAA). Niaaa. 2021. p. 1.
2. Trifan A, Minea H, Rotaru A, Stanciu C, Stafie R, Stratina E, et al. Predictive Factors for the Prognosis of Alcoholic Liver Cirrhosis. Med [Internet]. 2022;58(12).
3. Ramkissoon R, Shah VH. Alcohol Use Disorder and Alcohol-Associated Liver Disease. Alcohol Res Curr Rev. 2022;42(1).
4. Hendriks HFJ. Alcohol and Human Health: What Is the Evidence? Annu Rev Food Sci Technol [Internet]. 2020;11:1–21.
5. Axley PD, Richardson CT, Singal AK. Epidemiology of Alcohol Consumption and Societal Burden of Alcoholism and Alcoholic Liver Disease. Clin Liver Dis [Internet]. 2019;23(1):39–50.
6. Shield K, Manthey J, Rylett M, Probst C, Wettlaufer A, Parry CDH, et al. National, regional, and global burdens of disease from 2000 to 2016 attributable to alcohol use: a comparative risk assessment study. Lancet Public Heal [Internet]. 2020;5(1):e51–61.
7. Lefkowitch JH. Morphology of alcoholic liver disease. Clin Liver Dis [Internet]. 2005;9(1):37–53.
8. Torruellas C, French SW, Medici V. Diagnosis of alcoholic liver disease. World J Gastroenterol [Internet]. 2014;20(33):11684–99.
9. Hussen N, Zhu L, Tetangco E, Ellison S. Hepatoptosis in a Patient with Alcoholic Hepatitis. Am J Gastroenterol [Internet]. 2018;113(11):1581.
10. Lau K, Freyer-Adam J, Coder B, Riedel J, Rumpf HJ, John U, et al. Dose-response relation between volume of drinking and alcohol-related diseases in male general hospital inpatients. Alcohol Alcohol. 2008;43(1):34–8.
11. Simpson RF, Hermon C, Liu B, Green J, Reeves GK, Beral V, et al. Alcohol drinking patterns and liver cirrhosis risk: analysis of the prospective UK Million Women Study. Lancet Public Heal. 2019;4(1):e41–8.
12. Savolainen VT, Liesto K, Männikkö A, Penttilä A, Karhunen PJ. Alcohol Consumption and Alcoholic Liver Disease: Evidence of a Threshold Level of Effects of Ethanol. Alcohol Clin Exp Res. 1993;17(5):1112–7.
13. Åberg F, Färkkilä M, Männistö V. Interaction Between Alcohol Use and Metabolic Risk Factors for Liver Disease: A Critical Review of Epidemiological Studies. Alcohol Clin Exp Res. 2020;44(2):384–403.
14. Kondili LA, Taliani G, Cerga G, Tosti ME, Babameto A, Resuli B. Correlation of alcohol consumption with liver histological features in non-cirrhotic patients. Eur J Gastroenterol Hepatol. 2005;17(2).
15. Roerecke M, Vafaei A, Hasan OSM, Chrystoja BR, Cruz M, Lee R, et al. Alcohol Consumption and Risk of Liver Cirrhosis: A Systematic Review and Meta-Analysis. Am J Gastroenterol [Internet]. 2019;114(10):1574–86.
16. Askgaard G, Grønbæk M, Kjær MS, Tjønneland A, Tolstrup JS. Alcohol drinking pattern and risk of alcoholic liver cirrhosis: A prospective cohort study. J Hepatol. 2015;62(5):1061–7.
17. REHM J, TAYLOR B, MOHAPATRA S, IRVING H, BALIUNAS D, PATRA J, et al. Alcohol as a risk factor for liver cirrhosis: A systematic review and meta-analysis. Drug Alcohol Rev. 2010;29(4):437–45.
18. Moon SY, Son M, Kang YW, Koh M, Lee JY, Baek YH. Alcohol consumption and the risk of liver disease: a nationwide, population-based study. Front Med [Internet]. 2023;10(November):1–10.
19. Kamper-Jørgensen M, Grønbaek M, Tolstrup J, Becker U. Alcohol and cirrhosis: dose--response or threshold effect? J Hepatol [Internet]. 2004;41(1):25–30.
20. Corrao G, Bagnardi V, Zambon A, Arico S. Exploring the dose-response relationship between alcohol consumption and the risk of several alcohol-related conditions: a meta-analysis. Addiction [Internet]. 1999;94(10):1551–73.
21. Ishak KG, Zimmerman HJ, Ray MB. Alcoholic Liver Disease: Pathologic, Pathogenetic and Clinical Aspects. Alcohol Clin Exp Res. 1991;15(1):45–66.
22. Becker U, Deis A, Sorensen TI, Gronbaek M, Borch-Johnsen K, Muller CF, et al. Prediction of risk of liver disease by alcohol intake, sex, and age: A prospective population study. Hepatology. 1996;23(5).
23. Osna NA, Donohue TMJ, Kharbanda KK. Alcoholic Liver Disease: Pathogenesis and Current Management. Alcohol Res [Internet]. 2017;38(2):147–61.